05th week of 2017 patent applcation highlights part 24 |
Patent application number | Title | Published |
20170029407 | POTENT AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS | 2017-02-02 |
20170029408 | ANTIVIRAL COMPOUNDS | 2017-02-02 |
20170029409 | COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT | 2017-02-02 |
20170029410 | CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF | 2017-02-02 |
20170029411 | ANTIBACTERIAL 1H-INDAZOLE AND 1H-INDOLE DERIVATIVES | 2017-02-02 |
20170029412 | ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS | 2017-02-02 |
20170029413 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | 2017-02-02 |
20170029414 | PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | 2017-02-02 |
20170029415 | ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LpxC INHIBITORS | 2017-02-02 |
20170029416 | SWEET FLAVOR MODIFIER | 2017-02-02 |
20170029417 | CYCLOPROPANAMINE COMPOUND AND USE THEREOF | 2017-02-02 |
20170029418 | PYRIMIDINE COMPOUND AND MEDICAL USE THEREOF | 2017-02-02 |
20170029419 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2017-02-02 |
20170029420 | PHENYL-TRIAZOLO-PYRIDINE COMPOUNDS | 2017-02-02 |
20170029421 | TOLL-LIKE RECEPTOR-7 AND -8 MODULATORY 1H IMIDAZOQUINOLINE DERIVED COMPOUNDS | 2017-02-02 |
20170029422 | NOVEL SUBSTITUTED IMIDAZOQUINOLINES | 2017-02-02 |
20170029423 | PYRIDONE OR PYRIMIDONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 2017-02-02 |
20170029424 | IODONIUM ANALOGS AS INHIBITORS OF NADPH OXIDASES AND OTHER FLAVIN DEHYDROGENASES; FORMULATIONS THEREOF; AND USES THEREOF | 2017-02-02 |
20170029425 | NEW DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE | 2017-02-02 |
20170029426 | METHODS AND REAGENTS FOR RADIOLABELING | 2017-02-02 |
20170029427 | COMPOUNDS AND METHODS FOR ANTIVIRAL TREATMENT | 2017-02-02 |
20170029428 | Solid Forms and Formulations of Imidazopyrazine Compound | 2017-02-02 |
20170029429 | NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF | 2017-02-02 |
20170029430 | ANALOGUES OF 4H-PYRAZOLO[1,5-a] BENZIMIDAZOLE COMPOUND AS PARP INHIBITORS | 2017-02-02 |
20170029431 | 10',11'-MODIFIED SAXITOXINS USEFUL FOR THE TREATMENT OF PAIN | 2017-02-02 |
20170029432 | (+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF | 2017-02-02 |
20170029433 | TRANSFER HYDROGENATION OF CYCLOPAMINE ANALOGS | 2017-02-02 |
20170029434 | PHOSPHONIC ACID CATALYST IN DEHYDRATIVE CYCLIZATION OF 5 AND 6 CARBON POLYOLS WITH IMPROVED COLOR AND PRODUCT ACCOUNTABILITY | 2017-02-02 |
20170029435 | CORTISTATIN ANALOGUES AND SYNTHESES AND USES THEREOF | 2017-02-02 |
20170029436 | NEOSORAPHENS | 2017-02-02 |
20170029437 | Compositions and Methods for Treating Neoplasia, Inflammatory Disease and Other Disorders | 2017-02-02 |
20170029438 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | 2017-02-02 |
20170029439 | NOVEL MACROCYCLIC COMPOUNDS | 2017-02-02 |
20170029440 | PIPERIDINE/PIPERAZINE DERIVATIVES | 2017-02-02 |
20170029441 | AMIDO-SUBSTITUTED IMIDAZOPYRIDAZINES USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE AND/OR ANGIOGENESIS DISORDERS | 2017-02-02 |
20170029442 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2017-02-02 |
20170029443 | POLYMORPHIC FORMS AND CO-CRYSTALS OF A C-MET INHIBITOR | 2017-02-02 |
20170029444 | BORON-DIPYRROMETHENE FLUORESCENCE PROBES AND MANUFACTURING METHOD AND USE THEREOF | 2017-02-02 |
20170029445 | ASYMMETRIC AUXILIARY GROUP | 2017-02-02 |
20170029446 | Process Of Synthesizing Diisopropylamino-Disilanes | 2017-02-02 |
20170029447 | HYDROXIDE-CATALYZED FORMATION OF SILICON-OXYGEN BONDS BY DEHYDROGENATIVE COUPLING OF HYDROSILANES AND ALCOHOLS | 2017-02-02 |
20170029448 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | 2017-02-02 |
20170029449 | METHOD FOR ACQUIRING ONE OR A PLURALITY OF RECYCLABLE MATERIALS FROM SEEDS | 2017-02-02 |
20170029450 | ANTHRACENE-9, 10-DIONE DIOXIME COMPOUND PRODRUGS AND THEIR USES | 2017-02-02 |
20170029451 | BRANCHED CHAIN ACYCLIC NUCLEOSIDE PHOSPHONATE ESTERS AND METHODS OF SYNTHESIS AND USES THEREOF | 2017-02-02 |
20170029452 | PHENANTHROLINE PHOSPHONIC ACID DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 2017-02-02 |
20170029453 | BIS(PHOSPHINE)-CARBODICARBENE CATALYST COMPLEXES AND METHODS OF USING THE SAME | 2017-02-02 |
20170029454 | NKT CELL LIGANDS AND METHODS OF USE | 2017-02-02 |
20170029455 | URACYL SPIROOXETANE NUCLEOSIDES | 2017-02-02 |
20170029456 | NUCLEOTIDES FOR THE TREATMENT OF LIVER CANCER | 2017-02-02 |
20170029457 | METHODS FOR THE SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS | 2017-02-02 |
20170029458 | NOVEL TRITERPENE-GLYCOSIDES AS SWEETENERS OR SWEETENER ENHANCERS | 2017-02-02 |
20170029459 | Novel 7-Dehydrocholesterol Derivatives and Methods Using Same | 2017-02-02 |
20170029460 | LIMONIN EXTRACTION METHOD | 2017-02-02 |
20170029461 | HEPARIN AFFINITY TAG AND APPLICATIONS THEREOF | 2017-02-02 |
20170029462 | VIRUS REMOVAL MEMBRANE | 2017-02-02 |
20170029463 | SAA-DOMAIN-SPECIFIC ANTIBODIES AND PEPTIDE ANTAGONISTS AND USE THEREOF TO TREAT INFLAMMATORY DISEASES | 2017-02-02 |
20170029464 | VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD | 2017-02-02 |
20170029465 | PEPTIDES AND METHODS OF USING SAME | 2017-02-02 |
20170029466 | PEPTIDES WHOSE UPTAKE BY CELLS IS CONTROLLABLE | 2017-02-02 |
20170029467 | METHOD OF PRODUCING BIVALIRUDIN | 2017-02-02 |
20170029468 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS | 2017-02-02 |
20170029469 | CYCLOSPORIN ANALOGS | 2017-02-02 |
20170029470 | FUSION PROTEINS FOR USE AS IMMUNOGENIC ENHANCERS FOR INDUCING ANTIGEN-SPECIFIC T CELL RESPONSES | 2017-02-02 |
20170029471 | PCV2 ORF2 PROTEIN VARIANT AND VIRUS LIKE PARTICLES COMPOSED THEREOF | 2017-02-02 |
20170029472 | FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A | 2017-02-02 |
20170029473 | EVOLUTION OF BT TOXINS | 2017-02-02 |
20170029474 | POLYPEPTIDE AND ANTI-TUMOR AGENT | 2017-02-02 |
20170029475 | MSP NANOPORES AND USES THEREOF | 2017-02-02 |
20170029476 | ICE STRUCTURING PROTEIN | 2017-02-02 |
20170029477 | Fusion Molecules | 2017-02-02 |
20170029478 | High Molecular Weight, Post-Translationally Modified Protein Brushes | 2017-02-02 |
20170029479 | Modified FGF-21 Polypeptides Comprising an Internal Deletion and Uses Thereof | 2017-02-02 |
20170029480 | CHIMERIC FIBROBLAST GROWTH FACTOR 21 PROTEINS AND METHODS OF USE | 2017-02-02 |
20170029481 | Compounds That Bind to the Erythropoietin Receptor | 2017-02-02 |
20170029482 | NOVEL PURIFICATION PROCESS OF GONADOTROPIN | 2017-02-02 |
20170029483 | MURINE ANTI-NY-ESO-1 T CELL RECEPTORS | 2017-02-02 |
20170029484 | ISOLATED T CELL RECEPTORS AND METHODS OF USE THEREFOR | 2017-02-02 |
20170029485 | HUMAN TIM-3 FUSION PROTEIN CAPABLE OF BLOCKING TIM-3 SIGNALING PATHWAY | 2017-02-02 |
20170029486 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS | 2017-02-02 |
20170029487 | SELECTIVE INHIBITORS OF C-FOS AND THEIR ANTIPROLIFERATIVE PROPERTIES | 2017-02-02 |
20170029488 | Human Antibodies to Respiratory Syncytial Virus F Protein and Methods of Use Thereof | 2017-02-02 |
20170029489 | HUMAN MONOCLONAL ANTIBODY WITH SPECIFICITY FOR DENGUE VIRUS SEROTYPE 1 E PROTEIN AND USES THEREOF | 2017-02-02 |
20170029490 | SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES | 2017-02-02 |
20170029491 | ABSCOPAL EFFECT OF USPIO THERANOSIS AND IMMUNOTHERAPY FOR CANCER TREATMENT | 2017-02-02 |
20170029492 | HUMAN ANTIBODIES TO HUMAN DELTA LIKE LIGAND 4 | 2017-02-02 |
20170029493 | ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2 | 2017-02-02 |
20170029494 | Antigen Binding Constructs | 2017-02-02 |
20170029495 | Human Antibodies that Bind Human TNF-Alpha and Methods of Preparing the Same | 2017-02-02 |
20170029496 | Anti-IL-12 Antibodies and Compositions | 2017-02-02 |
20170029497 | IMMUNOGLOBULINS | 2017-02-02 |
20170029498 | USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN | 2017-02-02 |
20170029499 | METHODS FOR TREATING HEPCIDIN-MEDIATED DISORDERS | 2017-02-02 |
20170029500 | USE OF INHIBITORS OF LEUKOTRIENE B4 RECEPTOR BLT2 FOR TREATING ASTHMA | 2017-02-02 |
20170029501 | ANTI-EPHRINB2 ANTIBODIES AND METHODS USING SAME | 2017-02-02 |
20170029502 | ANTIBODY CONSTRUCTS FOR MSLN AND CD3 | 2017-02-02 |
20170029503 | ANTI-SIGLEC-15 ANTIBODIES AND USES THEREOF | 2017-02-02 |
20170029504 | ANTI-PVRIG ANTIBODIES AND METHODS OF USE | 2017-02-02 |
20170029505 | MULTIMERIC FC PROTEINS | 2017-02-02 |
20170029506 | Immunoglobulins Binding Human Vgamma9 Vdelta2 T Cell Receptors | 2017-02-02 |